Joel Simren

Moelndal, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Real-world performance of Lumipulse G plasma p-tau217: a six-month experience of a specialized clinical neurochemistry laboratory.

Real-world performance of Lumipulse G plasma p-tau217: a six-month experience of a specialized clinical neurochemistry laboratory.

Journal: Clinical chemistry and laboratory medicine

Published: March 10, 2026

Plasma Proteomic Changes in GRN and C9orf72 Frontotemporal Dementia.

Plasma Proteomic Changes in GRN and C9orf72 Frontotemporal Dementia.

Journal: European journal of neurology

Published: January 08, 2026

Influence of pneumatic tube system transport on cell count and spectrophotometry in cerebrospinal fluid.

Influence of pneumatic tube system transport on cell count and spectrophotometry in cerebrospinal fluid.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: December 17, 2025

Saliva phosphorylated tau concentration is not associated with Alzheimer's disease, cerebrospinal fluid or blood biomarkers.

Saliva phosphorylated tau concentration is not associated with Alzheimer's disease, cerebrospinal fluid or blood biomarkers.

Journal: Frontiers in neuroscience

Published: October 03, 2025

Correlation of Neurodegenerative Biomarkers and Functional Outcome in Patients with Relapsing-Remitting Multiple Sclerosis.

Correlation of Neurodegenerative Biomarkers and Functional Outcome in Patients with Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology international

Published: July 08, 2025

A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology.

A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology.

Journal: Nature medicine

Published: May 29, 2025

Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes.

Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes.

Journal: Science translational medicine

Published: February 05, 2025

Functional and Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels.

Functional and Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels.

Journal: Medicina (Kaunas, Lithuania)

Published: November 24, 2024

Alzheimer's disease-Biomarkers, clinical evaluation or both?

Alzheimer's disease-Biomarkers, clinical evaluation or both?

Journal: Journal of neuropsychology

Published: October 22, 2024

Cerebrospinal fluid proteome profiling across the Alzheimer's disease continuum: a step towards solving the equation for 'X'.

Cerebrospinal fluid proteome profiling across the Alzheimer's disease continuum: a step towards solving the equation for 'X'.

Journal: Molecular neurodegeneration

Published: September 25, 2024

Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay.

Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: August 05, 2024

Traumatic Encephalopathy Syndrome and Tauopathy in a 19-Year-Old With Child Abuse.

Traumatic Encephalopathy Syndrome and Tauopathy in a 19-Year-Old With Child Abuse.

Journal: Neurotrauma reports

Published: December 29, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026